Tissue-Based Testing
News on immunohistochemistry and other tissue-based testing methods.
Agilent, Akoya to Commercialize Workflow Tools for Tissue Biomarker Analysis
The end-to-end workflow products are intended for biopharmaceutical companies developing companion diagnostics for precision cancer therapeutics.
Functional Precision Medicine Firm Kiyatec Raises $18M in Series C Funding Round
The Clemson University spinout is developing live tissue-based models of cancer cells for use in predicting patients' individual drug responses.
The firm is aiming to commercialize its OncoPrism assay in 2023 as a laboratory-developed test to identify head and neck cancer patients eligible for checkpoint inhibitors.
Oncgnostics Epigenetic Cervical Cancer Test Wins Chinese Regulatory Approval
The GynTect assay detects oncogenic DNA methylation markers from cervical smear samples following abnormal cancer-screen findings.
Bio-Techne Nabs CE Mark for HPV Head and Neck Cancer Test, Completes Namocell Acquisition
The RNAscope ISH Probe High Risk HPV test detects E6/E7 mRNA and is intended to help inform treatment selection in oropharyngeal squamous cell carcinoma patients.